After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ZTS belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Zoetis Inc is $75.42B. A total of 2.74 million shares were traded on the day, compared to an average of 2.50M shares.
In the most recent transaction, Polzer Robert J sold 3,477 shares of ZTS for 177.46 per share on Nov 25 ’24. After the transaction, the Executive Vice President now owns 3,249 company shares. In a previous transaction on Nov 25 ’24, Polzer Robert J bought 3,477 shares at 177.46 per share.
Among the insiders who sold shares, Lagano Roxanne disposed of 923 shares on Apr 18 ’24 at a per-share price of $151.17. This resulted in the Executive Vice President holding 14,800 shares of ZTS after the transaction. In another insider transaction, Lagano Roxanne sold 923 shares at $173.33 per share on Mar 18 ’24. Company shares held by the Executive Vice President now total 15,723.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Zoetis Inc pays an annual dividend of $1.73, resulting in a dividend yield of 1.03%, and it has a price to earnings (P/E) ratio of 31.43. ZTS’s most recent ex-dividend date was 1.12% when it declared a $0.50 quarterly dividend that was paid in cash on 1/21/2025. Previously, the company paid the dividend on 10/31/2024 with an ex-dividend date of 0.9%. The ZTS stock dividend was $0.4320 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ZTS has a high of $200.53 and a low of $144.80.
As of this writing, ZTS has an earnings estimate of $1.38 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $1.44 per share and a lower estimate of $1.33.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ZTS’s latest balance sheet shows that the firm has $3.48B in Cash & Short Term Investments as of fiscal 2021. There were $6.74B in debt and $1.80B in liabilities at the time. Its Book Value Per Share was $11.59, while its Total Shareholder’s Equity was $4.54B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZTS is Buy with a score of 4.82.
